Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark E. Bunnage files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeffrey M. Leiden - $60.94M of VRTX open-market activity in the last 12 months
- Amit Sachdev - $28.38M of VRTX open-market activity in the last 12 months
- Reshma Kewalramani - $19.74M of VRTX open-market activity in the last 12 months
- Carmen Bozic - $11.31M of VRTX open-market activity in the last 12 months
- Charles F. Wagner Jr. - $6.38M of VRTX open-market activity in the last 12 months
- Duncan McKechnie - $5.66M of VRTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Mark E. Bunnage?
Mark E. Bunnage is a corporate insider, tracked as EVP, Chief Scientific Officer of VERTEX PHARMACEUTICALS INC / MA (VRTX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Mark E. Bunnage last file a Form 4?
The most recent primary Form 4 on record is dated 19 May 2026, one of 5 filings going back to 2026.
Has Mark E. Bunnage been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($3.00M) across all tracked filings.
Where can I see all of Mark E. Bunnage's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Mark E. Bunnage and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
